Fig. 5From: Development and characterization of mupirocin encapsulated in animal bone-derived hydroxyapatite for management of chronic woundsA–H Microbial plates showing evaluation of antibacterial activity of the formulations against Staphylococcus aureus (SA), Staphylococcus saprophyticus (SS), Klebsiella pneumonia (KP) and Escherichia coli (ES) and J The graphical representation of inhibition of zones against the bacteriaBack to article page